Search results for "Urology & Nephrology"

showing 10 items of 361 documents

Targeting Moderate and Severe Male Stress Urinary Incontinence With Adjustable Male Slings and the Perineal Artificial Urinary Sphincter: Focus on Pe…

2017

Purpose: To analyze perioperative complications and postoperative explantation rates for selected readjustable male sling systems and the perineal single-cuff artificial urinary sphincter (AUS) in a large, contemporary, multi-institutional patient cohort. Methods: Two hundred eighty-two male patients who underwent implantation between 2010 and 2012 in 13 participating institutions were included in the study (n = 127 adjustable male sling [n = 95 Argus classic, n = 32 Argus T], n = 155 AUS). Perioperative characteristics and postoperative complications were analyzed. The explantation rates of the respective devices were assessed using the Fisher exact test and the Mann-Whitney U-test. A Kapl…

medicine.medical_specialtyIntraoperative ComplicationComplicationsUrologyUrinary Incontinence Stress030232 urology & nephrologyUrology610 Medicine & healthUrinary incontinencelcsh:RC870-923Artificial urinary sphincter03 medical and health sciencessymbols.namesake0302 clinical medicinemedicine610 Medicine & healthFisher's exact testbusiness.industryPerioperativeOdds ratiolcsh:Diseases of the genitourinary system. UrologyNeurology030220 oncology & carcinogenesisCohortsymbolsUrinary Sphincter ArtificialOriginal ArticleNeurology (clinical)medicine.symptomComplicationbusinessInternational neurourology journal
researchProduct

Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large m…

2020

Abstract Background Aim of this study was to evaluate and compare perioperative outcomes of transperitoneal (TP) and retroperitoneal (TR) approaches in a multi-institutional cohort of minimally invasive partial nephrectomy (MI-PN). Material and methods All consecutive patients undergone MI-PN for clinical T1 renal tumors at 26 Italian centers (RECORd2 project) between 01/2013 and 12/2016 were evaluated, collecting the pre-, intra-, and postoperative data. The patients were then stratified according to the surgical approach, TP or RP. A 1:1 propensity score (PS) matching was performed to obtain homogeneous cohorts, considering the age, gender, baseline eGFR, surgical indication, clinical dia…

medicine.medical_specialtyIntraoperative ComplicationUrologymedicine.medical_treatmentOperative TimeSurgical approach030232 urology & nephrologyMinimally invasive partial nephrectomy Renal cell carcinoma Retroperitoneal Surgical approach Transperitoneal.lcsh:RC870-923lcsh:RC254-282NephrectomyArticle03 medical and health sciences0302 clinical medicineRenal cell carcinomamedicineMinimally invasive partial nephrectomy; Renal cell carcinoma; Retroperitoneal; Surgical approach; TransperitonealHumansRetroperitoneal SpaceRetrospective StudiesMinimally invasive partial nephrectomybusiness.industryRenal cell carcinoma; Minimally invasive partial nephrectomy; Transperitoneal; Retroperitoneal; Surgical approachTransperitonealPerioperativeRetroperitoneallcsh:Diseases of the genitourinary system. Urologylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseNephrectomyKidney NeoplasmsRenal cell carcinomaSurgerySettore MED/24Treatment Outcome030220 oncology & carcinogenesisPropensity score matchingCohortSurgeryLaparoscopyPositive Surgical MarginMinimally invasive partial nephrectomy; Renal cell carcinoma; Retroperitoneal; Surgical approach; Transperitoneal; Follow-Up Studies; Humans; Nephrectomy; Operative Time; Retroperitoneal Space; Retrospective Studies; Treatment Outcome; Kidney Neoplasms; LaparoscopybusinessAbdominal surgeryFollow-Up StudiesSurgical endoscopy
researchProduct

Intravenöse Eisensubstitution bei chronischer Erkrankung – bei wem, wann und wie?

2019

ZusammenfassungIn den letzten Jahren konnten wesentliche Fortschritte in der Erkennung und Behandlung des Eisenmangels erzielt werden, deren Ergebnisse auch für viele Fachgebiete und insbesondere mit Patienten mit chronisch-entzündlichen Erkrankungen relevant sind. Allerdings wird in der täglichen Praxis ein Eisenmangel vielfach nicht identifiziert und konsequent therapiert.Ein Eisenmangel kann – auch bevor eine Anämie auftritt – die Lebensqualität einschränken und den Verlauf der Grunderkrankung beeinflussen. Bei Patienten mit chronischen Erkrankungen sollte der Eisenstatus regelmäßig erfasst werden. Gerade bei Patienten mit chronisch-entzündlichen Erkrankungen sind die derzeit verfügbaren…

medicine.medical_specialtyIron uptakebusiness.industryAnemiaIRON PREPARATIONS030232 urology & nephrology10265 Clinic for Endocrinology and Diabetology610 Medicine & healthGeneral MedicineIron deficiency2700 General Medicine030204 cardiovascular system & hematologymedicine.diseaseEnteral administrationGastroenterology03 medical and health sciences0302 clinical medicineTolerabilityQuality of lifeInternal medicinemedicineIn patientbusiness
researchProduct

NephroCheck: should we consider urine osmolality?

2019

medicine.medical_specialtyLetterCritical Care030232 urology & nephrologyMEDLINEUrine030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineAcute Kidney Injury; Biomarkers Humans Insulin-Like Growth Factor Binding Proteins Research Design Tissue Inhibitor of Metalloproteinase-2 Urine Osmolar ConcentrationOsmolar Concentration03 medical and health sciences0302 clinical medicinemedicineHumansTissue Inhibitor of Metalloproteinase-2Intensive Care Medicinebusiness.industryOsmolar Concentrationlcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RC86-88.9Acute Kidney InjuryInsulin-Like Growth Factor Binding ProteinsResearch DesignEmergency medicineUrine osmolalitybusinessBiomarkersCritical Care
researchProduct

Lipoprotein abnormalities in chronic kidney disease and renal transplantation

2021

Chronic kidney disease (CKD) is one of the most important risk factors for cardiovascular disease (CVD). Despite the kidney having no direct implications for lipoproteins metabolism, advanced CKD dyslipidemia is usually present in patients with CKD, and the frequent lipid and lipoprotein alterations occurring in these patients play a role of primary importance in the development of CVD. Although hypertriglyceridemia is the main disorder, a number of lipoprotein abnormalities occur in these patients. Different enzymes pathways and proteins involved in lipoprotein metabolism are impaired in CKD. In addition, treatment of uremia may modify the expression of lipoprotein pattern as well as deter…

medicine.medical_specialtyLipoproteins030232 urology & nephrologyDiseaseReview030204 cardiovascular system & hematologyurologic and male genital diseasesGastroenterologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineInternal medicineChronic kidney diseasemedicinelcsh:ScienceEcology Evolution Behavior and SystematicsKidneybusiness.industryHypertriglyceridemiaPaleontologymedicine.diseaseCardiovascular diseaseLipidsUremiafemale genital diseases and pregnancy complicationsTransplantationmedicine.anatomical_structureSpace and Planetary Sciencelipids (amino acids peptides and proteins)lcsh:QbusinessDyslipidemiaKidney diseaseLipoprotein
researchProduct

Sodium-glucose cotransporter 2 inhibition : towards an indication to treat diabetic kidney disease

2020

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin–angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with overt DKD. However, the indication of this drug class is still blood glucose lowering in type 2 diabetic patients with estimated glomerular filtration rate >45mL/min/1.73m2. Based on the new evidence, several scientific societies have emphasized the preferential prescription of SGLT2i for patients at risk of heart failure or kidney disease, but still within the limits set by health authorities. A r…

medicine.medical_specialtyMedicina030232 urology & nephrologyRenal functionReviewsType 2 diabetes030204 cardiovascular system & hematologyDiabetic nephropathy03 medical and health sciences0302 clinical medicineSodium-Glucose Transporter 2Internal medicineDiabetes mellitusDiabetic nephropathiesmedicineChronic renal failureHumansDiabetic NephropathiesDiabetic kidney diseaseESRDSodium-Glucose Transporter 2 InhibitorsTransplantationbusiness.industryType 2 diabetesNefropaties diabètiquesmedicine.diseasePrognosisBlood pressureDiabetes Mellitus Type 2NephrologyHeart failureSodium/Glucose Cotransporter 2Insuficiència renal crònicabusinessSGLT2 inhibitorsKidney disease
researchProduct

Epidemiological, Clinical and Morphological Characteristics of Immunoglobulin a Nephropathy in Latvia

2020

Abstract Immunoglobulin A nephropathy (IgAN) is the most common chronic glomerulopathy with variable clinical manifestations. IgAN diagnostics became possible in Latvia in 2013. The study aim was to describe IgAN manifestations in the Latvian population by analysing epidemiological, clinical, histological data, and reveal factors that might determine the course of the disease. The retrospective, one-centre study included biopsy-proven IgAN patients over a five-year period in the Nephrology Centre at Pauls Stradiņš Clinical University Hospital. Data from inpatient and outpatient medical records were collected. The study included 69 patients with histologically confirmed IgAN (23% of all rena…

medicine.medical_specialtyMultidisciplinaryGeneral interestkidney diseaseSciencekidney biopsyQnephrology030232 urology & nephrologyimmunoglobulin aurologic and male genital diseases03 medical and health sciences0302 clinical medicineImmunologyEpidemiologymedicine030212 general & internal medicineImmunoglobulin A NephropathyglomerulonephritisProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
researchProduct

The impact of perioperative complications on favorable outcomes after artificial urinary sphincter implantation for post-prostatectomy incontinence

2020

ABSTRACT Objective To investigate the effect of perioperative complications involving artificial urinary sphincter (AUS) implantation on rates of explantation and continence as well as health-related quality of life (HRQOL). Materials and methods Inclusion criteria encompassed non-neurogenic, moderate-to-severe stress urinary incontinence (SUI) post radical prostatectomy and primary implantation of an AUS performed by a high-volume surgeon (>100 previous implantations). Reporting complications followed the validated Clavien-Dindo scale and Martin criteria. HRQOL was assessed by the validated IQOL score, continence by the validated ICIQ-SF score. Statistical analysis included Chi (2) test, M…

medicine.medical_specialtyMultivariate analysisVisual analogue scaleUrinary Incontinence StressUrologymedicine.medical_treatmentUrinary system030232 urology & nephrologyUrinary incontinencelcsh:RC870-923Artificial urinary sphincter03 medical and health sciences0302 clinical medicineurinary sphincter artificialQuality of lifeMedicinebusiness.industryProstatectomyPerioperativelcsh:Diseases of the genitourinary system. UrologySurgeryquality of life030220 oncology & carcinogenesisQuality of LifeUrinary Sphincter Artificialmedicine.symptomurinary incontinence stressbusinessInternational braz j urol
researchProduct

Comparison of three different antibiotic protocols in transurethral resection of bladder tumour and the possible infectious risk factors: A non-rando…

2018

Introduction: We sought to investigate three different antibiotic protocols in transurethral resection of a bladder tumour (TURBT), and the possible infectious risk factors of this surgery.Methods: We conducted a non-randomized, prospective study, gathering cases of patients in whom TURBT had been performed. The sample was divided into three groups based on those who received antibiotics as: a single preoperative dose (Group A); a preoperative dose, plus a long protocol during the hospitalization (Group B); a preoperative dose, plus a long protocol during the hospitalization, plus five days at home (Group C). Intra- and postoperative data that could be relevant to infections was gathered.Re…

medicine.medical_specialtyMultivariate analysismedicine.diagnostic_testmedicine.drug_classbusiness.industryUrologyAntibiotics030232 urology & nephrologyOdds ratioUrineCystoscopyPerioperativeGroup BSurgery03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesismedicinebusinessProspective cohort studyOriginal Research
researchProduct

Remeex® System Effectiveness in Male Patients with Stress Urinary Incontinence

2021

Background: When conservative management fails, patients with stress urinary incontinence (SUI) are considered for surgical treatment. Simpler, more economical and less invasive surgical techniques, such as the Remeex® system, have been developed. Objectives: To analyze the objective effectiveness of the Remeex® system in the treatment of male stress urinary incontinence. To study survival and complication rates of the Remeex® system in male SUI patients. Materials and methods: Prospective observational study between July 2015 and May 2020. Group A (n = 7

medicine.medical_specialtyMultivariate analysisslings030232 urology & nephrologyeffectivenessUrinary incontinenceArticleGroup B03 medical and health sciences0302 clinical medicineMedicinemale stress urinary incontinenceRemeex® systembusiness.industryRGeneral MedicineSurgeryExact test030220 oncology & carcinogenesisMedicineObservational studyAnalysis of varianceImplantRemeex<sup>®</sup> systemmedicine.symptombusinessComplicationJournal of Clinical Medicine
researchProduct